1. Home
  2. AQST vs XPOF Comparison

AQST vs XPOF Comparison

Compare AQST & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • XPOF
  • Stock Information
  • Founded
  • AQST 2004
  • XPOF 2017
  • Country
  • AQST United States
  • XPOF United States
  • Employees
  • AQST N/A
  • XPOF N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • AQST Health Care
  • XPOF Consumer Discretionary
  • Exchange
  • AQST Nasdaq
  • XPOF Nasdaq
  • Market Cap
  • AQST 272.9M
  • XPOF 295.1M
  • IPO Year
  • AQST 2018
  • XPOF 2021
  • Fundamental
  • Price
  • AQST $3.40
  • XPOF $7.40
  • Analyst Decision
  • AQST Strong Buy
  • XPOF Buy
  • Analyst Count
  • AQST 6
  • XPOF 9
  • Target Price
  • AQST $10.67
  • XPOF $13.94
  • AVG Volume (30 Days)
  • AQST 1.6M
  • XPOF 470.2K
  • Earning Date
  • AQST 08-05-2025
  • XPOF 07-31-2025
  • Dividend Yield
  • AQST N/A
  • XPOF N/A
  • EPS Growth
  • AQST N/A
  • XPOF N/A
  • EPS
  • AQST N/A
  • XPOF N/A
  • Revenue
  • AQST $54,228,000.00
  • XPOF $317,536,000.00
  • Revenue This Year
  • AQST N/A
  • XPOF $1.62
  • Revenue Next Year
  • AQST $45.71
  • XPOF $6.11
  • P/E Ratio
  • AQST N/A
  • XPOF N/A
  • Revenue Growth
  • AQST 5.29
  • XPOF N/A
  • 52 Week Low
  • AQST $2.12
  • XPOF $6.64
  • 52 Week High
  • AQST $5.80
  • XPOF $18.95
  • Technical
  • Relative Strength Index (RSI)
  • AQST 58.21
  • XPOF 36.52
  • Support Level
  • AQST $3.13
  • XPOF $7.54
  • Resistance Level
  • AQST $3.33
  • XPOF $7.72
  • Average True Range (ATR)
  • AQST 0.21
  • XPOF 0.40
  • MACD
  • AQST -0.03
  • XPOF -0.10
  • Stochastic Oscillator
  • AQST 46.94
  • XPOF 6.84

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: